Nature Medicine, doi:10.1038/s41591-021-01312-x
Authors
Eric Wu; Kevin Wu; Roxana Daneshjou; David Ouyang; Daniel E. Ho; James Zou
- Pages
- 3
- Published in
- United States of America
How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals
27 Mar 2021
Accessing this content requires a membership
If your institution is a member, please log into Policy Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.
Add to list
Citation
Zou, E., 2021. How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals, Stanford Institute for Human-Centered Artificial Intelligence.
United States of America.
Retrieved from https://coilink.org/20.500.12592/7f5b4q on 30 Sep 2024. COI: 20.500.12592/7f5b4q.
Full-page Screenshot
